Inconsistent state immunization laws complicate pharmacy operations and limit patient access.
|Articles|July 1, 2004
- Volume 0 0
Atorvastatin May Help with Alzheimer's Disease
Advertisement
A study of 63 individuals with mild-to-moderateAlzheimer's disease found that they benefitedfrom taking atorvastatin. Those taking the statinshowed less decline on memory tests and brainfunction, compared with individuals who did nottake the medication.
In 2000, the researchers reviewed 56,000patient records in a database and discoveredthat patients on statins were 70% less likely to bediagnosed with Alzheimer's disease, comparedwith those who were not. Also, more recently,similar studies have found a lower rate ofAlzheimer's disease in patients taking statins.
Articles in this issue
over 22 years ago
Bloodstream Infection Risk Is Higher for Diabeticsover 22 years ago
Research Links Diabetes with Alzheimer'sover 22 years ago
Individuals with Chronic Pain Keep Quietover 22 years ago
Association Redesigns Web Siteover 22 years ago
Fibromyalgia Hits Individuals Differentlyover 22 years ago
Procedure May Relieve Agony of Spinal Cord Injuriesover 22 years ago
Europeans Are Slow to Seek Treatmentover 22 years ago
Intervention Curbs Asthma in Childrenover 22 years ago
Vaccine at Birth May Diminish Allergiesover 22 years ago
Asthma in Women Is Greater with Acetaminophen UseAdvertisement
Related to this article
OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.
Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.
Across every setting, the pharmacist's role is to build reliable systems around patients so stroke prevention remains safe and sustainable across the care continuum.
Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.
Like enzymes and coenzymes, monitoring devices and pharmacists may achieve more together than either can alone.
Every responsibility described in this issue depends on a pharmacy workforce with enough time and support to carry it.
Advertisement
Advertisement
Trending on Pharmacy Times
1
mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients
2
Asundexian Receives FDA Approval, Becomes First FXIa Inhibitor for Secondary Stroke Risk Reduction
3
Inside the OCEANIC-STROKE Trial and What Asundexian Means for the Future of Stroke Prevention
4
FDA Reportedly Shelves Commissioner's National Priority Voucher Program
5